Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.

Slides:



Advertisements
Similar presentations
PAYING FOR PERFORMANCE In PUBLIC HEALTH: Opportunities and Obstacles Glen P. Mays, Ph.D., M.P.H. Department of Health Policy and Administration UAMS College.
Advertisements

MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
Coordinating Care Across Funded Providers to Support Retenion in Care: The In+Care Campaign in RI. Aadia Rana, MD Assistant Professor of Medicine Miriam.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Cascade The Continuum of HIV Care Florida, 2012 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2012, as of 06/30/2013.
Differences in the availability of medicines used for chronic and acute conditions in developing countries Alexandra Cameron International Conference on.
The HIV Engagement in Care Cascade Edward Gardner, MD Associate Professor of Medicine Denver Public Health University of Colorado Denver.
Michelle O’Reilly. Quantitative research is outcomes driven Qualitative research is process driven Please offer up your definitions.
Cascade The Continuum of HIV Care Florida, 2013 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2013, as of 06/30/2014.
Adolescents and HIV Alison Jenkins, UNICEF Tanzania Cover photo: © Khanga Rue Media/2014/Olvera.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Chicago Housing for Health Partnership: HIV Outcomes David Buchanan MD MS, Romina Kee MD MPH, Laura Sadowski MD MPH, Diana Garcia MPH North American Housing.
Illustrating the HIV Care Continuum in U.S. Cities
Alternative antiretroviral monitoring strategies for HIV-infected patients in resource-limited settings: Opportunities to save more lives? R Scott Braithwaite,
Integrating Evidence-Based Practice Into QI to Improve Patient Outcomes in HIV: Viral Load Suppression Victoria Lieb, ACRN, MPH; Carla Rossi, MD; Jaime.
Illustrating the HIV Care Continuum in U.S. Cities Chicago, IL.
Illustrating the HIV Care Continuum in U.S. Cities New Orleans, LA.
Illustrating the HIV Care Continuum in U.S. Cities Philadelphia, PA.
The Hotspotters Retention and VL Supression Monitoring Project Ivy Clinic, Arnot Ogden Medical Center DRAFT Quality Improvement Team  Clinical Coordinator.
Ryan White HIV/AIDS Part C Capacity Development Program (HRSA )
Discussion Gitanjali Batmanabane MD PhD. Do you look like this?
Community Feedback and Involvement in [Health Department’s] Proposed Data to Care Program [Name of Provider Session Date of Provider Session]
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Effectiveness of Micronutrient-rich Lipid Nutrient Supplements in Delaying Clinical Progression of HIV in Malawian Adults Heidi Sandige, MD.
Effects of Patient Tracking Systems and Providers Incentives on Patient Appointment Keeping Rwanda Pilot Study Report Nyamusore Jose 1 *, Hinda Ruton 1,
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Clinical Quality Management: Guiding Better HIV Care USCA Sunday, September 13, 2015.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
eHARS to CAREWare Pilot Project Update and Training
Management and Development for Health (MDH)
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
Using Existing Datasets for Local Evaluation Studies of the CARE Act Computerized Networking of HIV Providers Workshop May 8, 2003.
I. Jean Davis, PhD, PA, AAHIVS Manager - Clinical Services Desert AIDS Project.
Manya Magnus, Ph.D., M.P.H., Jane Herwehe, M.P.H., Laura Andrews, M.P.H., R.N., Laura Gibson, M.B.A., Nathan Daigrepont, Jordana M. De Leon, M.P.H., Newton.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
Intervention Strategy in Improving ART Adherence In Tanzania Salama Mwakisu-MSH, Dr D Sando-NACP, Dr R. Malele-MUHAS, Bernard Rabiel- NACP, Dr G. Somi-NACP,
The Continuum of HIV Care Florida, 2014 The Continuum of HIV Care Florida, 2014 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2014, as of.
Michael J. Mugavero, MD, MHSc Associate Professor of Medicine University of Alabama at Birmingham Birmingham, Alabama Elements of the Care Continuum FORMATTED:
MINNESOTA’S HIV TREATMENT CASCADE April, Introduction.
EBM --- Journal Reading Presenter :葉麗雯 Date : 2005/10/27.
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
1 An Introduction to Performance Measurement for Quality Improvement Presenters: Lori DeLorenzo, Marlene Matosky & Benjamin Harris Wednesday, November.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
1 Meet the Author Webinar March 15, Ground Rules for Webinar Participation Actively participate and write your questions into the chat area during.
Date of download: 6/23/2016 From: The Anticipated Clinical and Economic Effects of 90–90–90 in South Africa Ann Intern Med. Published online May 31, 2016.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Quick Review This presentation is the first in a series of presentations intended to familiarize you with disparities calculation Part I: YOU ARE HERE!
ADDRESSING THE ACHILLES’ HEEL OF HIV TREATMENT SUCCESS José M
TITLE Differentiated Care for People who inject Drugs, Men who have sex with men, Sex workers, Transgender people, Prisoners and other people living in.
Illustrating the HIV Care Continuum in U.S. Cities
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Title Factors associated with viral suppression among adolescents living with HIV in Cambodia “No conflicts of interest to declare”
UMRG 3rd Learning Session: July 19th, 2012
Catalina Sol, MPH John Nelson, PhD, CPNP Tisha Wheeler, MSc
CIIS Implementation in Progress Mari-Lynn Drainoni, PhD, MEd
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
Stacey A. Rizza, MD, Robin J. MacGowan, MPH, David W
Illustrating the HIV Care Continuum in U.S. Cities
Elements of the Care Continuum
Improving Attendance in the Pediatric Weight Management Clinic
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Let’s end aids, long island.
Retention: What It Means for You
Management and Development for Health (MDH)
Sustaining Primary Care-Public Health Partnerships for Engagement in Care – The Partnerships for Care Demonstration Project Sue Lin, PhD, MS Director,
Estimating the State-Specific Impact of the HRSA Ryan White HIV/AIDS Program December 13, 2018 Pamela Klein, MSPH, PhD Health Scientist, Division of Policy.
Illustrative Cluster Detection and Response Strategy
Why Quality Matters in ART Programs
Presentation transcript:

Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS PATIENT CARE and STDs

Access to care has long been recognized as a vital factor in promoting and sustaining health engagement means the processes of linkage to care and retention in care

Engagement Delayed linkage and poor retention in outpatient HIV care → delayed receipt of antiretroviral medications, higher rates of viral load failure, and increased morbidity and mortality patients engaged in clinical care, better retention → reduced risk transmission, viral load suppression Retention in care is being recognized as a crucial step in maximizing patient outcomes

We reviewed the available published literature and summarized findings of the most commonly used measures to ascertain retention in outpatient HIV medical Measures of retention in care – Studies have typically included only scheduled outpatient medical appointments HIV biomarkers have been used to measure linkage and retention in HIV care, acting as a surrogate for a completed visit

Missed visits 1, 4, 0, 1 Appointment adherence 80%, 33%, 100%, 66% Visit constancy 100%, 50%, 75%, 25% Gaps in care B, D had a gap of over 6 months HRSA HAB medical visits performance measure A, B, and C had 2 visits, D not

The clinician’s perspective missed visits and gap in care as intuitive measures of retention Patient’s patterns of missed visits are likely taken into account by providers in determining the time interval for a subsequent clinic visit studies have shown these 2 measures associated with patient outcomes including clinical events and mortality.

The administrator’s perspective Appointment adherence and HRSA HAB may be preferable for administrators allow for longitudinal tracking of retention in care and also for setting an overall clinic benchmark (e.g., >80%) inform local, regional and/or national planning and resource allocation

Researcher’s perspective The missed visits measure has been widely used particularly for preliminary research and short-term observation periods. appointment adherence and visit constancy may be preferable for research purposes, particularly for longer observation periods

Requisite clinic visit data visit constancy, gaps in care, and the HRSA HAB are calculated based on completed visits only only ‘‘no show’’ visits have been included in the missed visit and appointment adherence, but there are issues related to the timing of cancelled visits worth noting

Impact of clinic scheduling practices Clinics with automatic rescheduling of missed visits may lead to artificially poor missed visit and appointment adherence results Considerable variability exists among HIV clinics in the availability and approach to handling unscheduled or acute care visits

Computational issues missed visits and appointment adherence – simplest gaps and HRSA HAB – calculation of the time interval between completed visits Constancy – the observation period of interest be divided into intervals of interest

Sensitivity in capturing disease severity and stage of treatment HRSA HAB, the gaps – insensitive in capturing retention as it relates to issues of disease severity and stage, and rather represents a minimum standard of retention in care missed visit and appointment adherence – visit frequency reflects the disease severity and stage of treatment for each individual patient constancy – the capacity to account for severity and stage of treatment through variation of the time interval

With growing emphasis on ‘‘test and treat’’ approaches to HIV prevention, there is a clear need for additional engagement in HIV care research future research should evaluate the impact of such visits and their inclusion in HIV retention measures on patient outcomes

This article provides a synthesis of the most commonly used measures of retention in HIV care, their methodological and conceptual strengths and limitations, and suggests situations in which certain measures may be preferred over others